Health care stocks were mixed Wednesday afternoon with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) adding 0.3%.
The iShares Biotechnology ETF (IBB) rose 1.2%.
In corporate news, CVS Health (CVS) shares jumped past 12% as a Q3 revenue beat overshadowed an earnings miss.
AstraZeneca (AZN) four senior executives in China, including two former employees, are being investigated for alleged violations of Chinese laws on drug importation and data privacy, Bloomberg reported, citing the company. AstraZeneca shares were falling 3.2%.
Novo Nordisk (NVO) reported Q3 earnings Wednesday of 6.12 Danish kroner ($0.88) per diluted American depositary share, up from 5 kroner a year earlier and above the expectation of three analysts polled by Capital IQ calling for 5.95 kroner. Q3 net sales were 71.31 billion kroner, up from 58.73 billion kroner in the year-ago period but below the Capital IQ consensus analyst estimate of 71.87 billion kroner. Novo shares shed 3.7%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。